News in brief: Genome-wide microarray testing funded for MM patients; Childhood cancer’s long shadow; New risk tool predicts PICC thrombosis

Medicare item for genome-wide microarray testing in MM A new MBS item for genome-wide microarray testing (GWMA) for people with multiple myeloma will be introduced from 1 November. Item 73391 will allow for the diagnosis and monitoring of multiple myeloma, as a complementary service to fluorescence in-situ hybridisation (FISH) testing currently provided under item 73290. ...

Already a member?

Login to keep reading.

© 2021 the limbic